A UK research team has developed a pioneering blood test that could change the way lung cancer is detected and monitored.
Quilter's AI designed a working 843-component Linux computer in 38 hours—a task that typically takes engineers 11 weeks. Here's how they did it.
CLEVELAND--(BUSINESS WIRE)--Cleveland Diagnostics, Inc., a pioneering, commercial-stage precision oncology company, announced today that the U.S. Food and Drug Administration (FDA) has approved the ...
Abstract: Test-time adaptation (TTA) leverages real-time updates with test samples to effectively address distribution shifts. Previous TTA methods have achieved stable results in scenarios with ...
Solid-state battery developer QuantumScape announced it hit another key goal for 2025, beginning shipments of its B1 sample cells featuring separators produced using its proprietary Cobra process. The ...
Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. As part of its bid to transform the future of cancer screening and seize control of ...
India conducted an unprecedented night test launch of the Agni-Prime medium-range ballistic missile (MRBM) from a rail-based mobile launcher on September 24, according to an Indian Ministry of Defense ...
If a medical test result is inconclusive, the sample did not provide enough information to confirm a positive or negative result. A person may need another test. People can have various medical tests ...
London-based Quantum Motion Technologies Ltd. announced today it has delivered the industry’s first quantum computer built using traditional semiconductor chipmaking processes, the same technology ...
Researchers at the Johns Hopkins Kimmel Cancer Center, Johns Hopkins All Children's Hospital, and four other institutions have devised a novel method to test for prostate cancer using biomarkers ...
Microsoft's latest computing system uses micro-LEDs and camera sensors to perform calculations. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. A ...
A urine-based biomarker panel detected prostate cancer in 91% of specimens with a diagnostic accuracy of 78.6% to 85.7%, according to a study published Sept. 2 in eBioMedicine. Led by a team from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results